{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:28:14Z","timestamp":1740104894726,"version":"3.37.3"},"reference-count":78,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"vor","delay-in-days":27,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"crossref","award":["83884 and 111938"],"award-info":[{"award-number":["83884 and 111938"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"crossref"}]},{"name":"J\u00e1nos Bolyai Research Fellowship awarded by the Hungarian Academy of Sciences","award":["no number is available"],"award-info":[{"award-number":["no number is available"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2015,7]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>In recent years, increasing intravenous mephedrone use was reported in several countries. The aim of this study was to describe the characteristics of such a form of mephedrone use, while identifying the differences between injectors and non\u2010injectors in patterns of mephedrone use and psychiatric symptom status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred and forty\u2010five mephedrone users were surveyed on patterns of mephedrone use using a structured questionnaire as well as the Brief Symptom Inventory.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Majority of users received mephedrone from acquaintances and used it in discos\/parties settings regarding both first and current mephedrone use. Intranasal use was the most typical route of administration (84.4%). Injectors (11%) used the drug more frequently and in higher dosages. This group included a greater proportion of opiate users (37.5%) and showed more diffuse psychiatric symptoms. Regarding the predictors of being an injector, heroin use showed the highest odds ratio.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Intravenous mephedrone use is associated with a higher risk of harmful drug use, elevated psychiatric symptom profile and increased possibility of mephedrone being considered as an addictive substance. These findings might be important in efficient treatment planning. Copyright \u00a9 2015 John Wiley &amp; Sons, Ltd.<\/jats:p><\/jats:sec>","DOI":"10.1002\/hup.2490","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T07:15:45Z","timestamp":1438067745000},"page":"233-243","source":"Crossref","is-referenced-by-count":14,"title":["Is there any difference in patterns of use and psychiatric symptom status between injectors and non\u2010injectors of mephedrone?"],"prefix":"10.1002","volume":"30","author":[{"given":"M\u00e1t\u00e9","family":"Kapit\u00e1ny\u2010F\u00f6v\u00e9ny","sequence":"first","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"},{"name":"Doctoral School of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"},{"name":"Ny\u00edr\u0151 Gyula Hospital Drug Outpatient and Prevention Center  Budapest Hungary"},{"name":"Faculty of Health Sciences Semmelweis University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Merv\u00f3","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"},{"name":"Doctoral School of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1t\u00e9","family":"Kert\u00e9sz","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Corazza","sequence":"additional","affiliation":[{"name":"School of Life and Medical Sciences University of Hertfordshire  Hatfield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Farkas","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"},{"name":"Doctoral School of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"},{"name":"Ny\u00edr\u0151 Gyula Hospital Drug Outpatient and Prevention Center  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6ngyi","family":"K\u00f6k\u00f6nyei","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00f3bert","family":"Urb\u00e1n","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Demetrovics","sequence":"additional","affiliation":[{"name":"Institute of Psychology E\u00f6tv\u00f6s Lor\u00e1nd University  Budapest Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12038"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bks085"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.04.2010.2879"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.15288\/jsa.2006.67.493"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1108\/17459261211286654"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110378370"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.02.011"},{"volume-title":"Statistical Power Analysis for the Behavioral Sciences","year":"1988","author":"Cohen J","key":"e_1_2_8_9_1"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881113480987"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2010.10399781"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990622"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcq134"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.312"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/jth134"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/16066351003695631"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.342"},{"volume-title":"United Kingdom Drug Situation: Annual Report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2010","year":"2010","author":"Davies C","key":"e_1_2_8_18_1"},{"volume-title":"Brief Symptom Inventory","year":"1975","author":"Derogatis LR","key":"e_1_2_8_19_1"},{"volume-title":"BSI Brief Symptom Inventory. Administration, Scoring, and Procedures Manual","year":"1993","author":"Derogatis LR","key":"e_1_2_8_20_1"},{"key":"e_1_2_8_21_1","first-page":"44","article-title":"MixMag drugs survey","volume":"225","author":"Dick D","year":"2010","journal-title":"Mix Mag"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/34.3.162"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2000.10400233"},{"key":"e_1_2_8_24_1","article-title":"Druglink street drug trends survey 2012","author":"DrugScope","year":"2012","journal-title":"DrugLink November\/December 2012"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.346"},{"volume-title":"Joint Report on a New Psychoactive Substance: 4\u2010Methylmethcathinone (Mephedrone)","year":"2010","author":"Europol\u2010EMCDDA","key":"e_1_2_8_26_1"},{"volume-title":"2011 Annual Report on the State of the Drugs Problem in Europe","year":"2011","author":"EMCDDA","key":"e_1_2_8_27_1"},{"volume-title":"HIV in Injecting Drug Users in the EU\/EEA, Following a Reported Increase of Cases in Greece and Romania","year":"2011","author":"EMCDDA","key":"e_1_2_8_28_1"},{"volume-title":"The State of the Drugs Problem in Europe","year":"2012","author":"EMCDDA","key":"e_1_2_8_29_1"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03719.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/emj.2010.096636"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1992.tb00434.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2297"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1465-3362.2011.00288.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.110.032433"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.176.3.285"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2011.05.012"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/815424"},{"volume-title":"EDRS Drug Trends Bulletin","year":"2010","author":"Matthews AJ","key":"e_1_2_8_39_1"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.5042\/daat.2010.0123"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2007.10399875"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2011.08.003"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100907"},{"key":"e_1_2_8_44_1","unstructured":"NACD and PHIRB (National Advisory Committee on Drugs and Public Health Information and Research Branch).2011.Drug use in Ireland and Northern Ireland: first results from the 2010\/2011 drug prevalence survey[Online]. Available:http:\/\/www.drugs.ie\/resourcesfiles\/research\/2011\/NACDdrug_use_irelandNov2011.pdf"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.209338"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.581989"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)80013-7"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100897"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.09.009"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1625"},{"key":"e_1_2_8_51_1","first-page":"7","article-title":"Mephedrone: the future of drug dealing?","volume":"25","author":"Power M","year":"2009","journal-title":"Druglink"},{"volume-title":"Mephedrone Report","year":"2009","author":"Psychonaut Web Mapping Research Group","key":"e_1_2_8_52_1"},{"key":"e_1_2_8_53_1","first-page":"29","article-title":"The phenomenon of drug change in the interviews with injecting drug users","volume":"27","author":"R\u00e1cz J","year":"2012","journal-title":"Psychiatr Hung"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60891-4"},{"key":"e_1_2_8_55_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e318266c70c"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881105056660"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.05.003"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0666"},{"volume-title":"Drug Misuse Declared: Findings from the 2010\/11 British Crime Survey England and Wales","year":"2011","author":"Smith K","key":"e_1_2_8_59_1"},{"key":"e_1_2_8_60_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106063274"},{"key":"e_1_2_8_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2009.09.002"},{"key":"e_1_2_8_62_1","unstructured":"The National Treatment Agency for Substance Misuse.2012.Club Drugs: Emerging Trends and Risks. [Online]. Available:http:\/\/www.nta.nhs.uk\/uploads\/clubdrugsreport2012%5B0%5D.pdf"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-7622-5-2"},{"key":"e_1_2_8_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200304110-00014"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2014.01.027"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2012.01.008"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2007.02.005"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.11.014"},{"key":"e_1_2_8_69_1","unstructured":"WinstockAR MitchesonL.2010. The annual Mixmag drugs survey 2010 [Online]. Available:www.menincarter.net\/mixmag\/. [Accessed]."},{"key":"e_1_2_8_70_1","unstructured":"WinstockAR.2011. \u2018The 2011 Mixmag drugs survey\u2019. Mixmag March 49\u201359."},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03130.x"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2011.03502.x"},{"volume-title":"Early Results of the Headline Findings from GDS 2012 [Online]","year":"2012","author":"Winstock AR","key":"e_1_2_8_73_1"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/dta.316"},{"key":"e_1_2_8_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2012.04.020"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs107"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/14659891.2012.661025"},{"key":"e_1_2_8_78_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03066.x"},{"key":"e_1_2_8_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490436055"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2490","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.2490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:50:06Z","timestamp":1696405806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["10.1002\/hup.2490"],"URL":"https:\/\/doi.org\/10.1002\/hup.2490","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"type":"print","value":"0885-6222"},{"type":"electronic","value":"1099-1077"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}